At a glance
ClinicalIndex Comparison RecordN/ACompleted· 81,597 enrolled
Drug / intervention
Insecticide-treated net (BASF Incerceptor)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Stimulating Private Sector Malaria Control: The Outgrower Opportunity
In Brief
A clinical study evaluating Insecticide-treated net (BASF Incerceptor) for Malaria. Completed, enrolled 81,597 participants across 1 site.
Detailed Summary
Preliminary evidence from ongoing research provides strong indications that protecting farmers from malaria would be profitable for outgrowing agribusinesses in sub-Saharan Africa. The study team invests in experimental research to investigate this conjecture in more detail.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMalaria
CountriesZambia
Collaborators--
Timeline
N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartDec 2010
First PostedJul 2011
Primary CompletionDec 2011
Study CompletionDec 2013
TodayJul 2026
First PostedJul 20, 2011
Enrollment StartDec 1, 2010
Primary CompletionDec 1, 2011
Study CompletionDec 1, 2013
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 15.0 years ago
Interventions
Insecticide-treated net (BASF Incerceptor)device
One per farmer, once during the 2010-2011 season